Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 263. Отображено 190.
22-11-2007 дата публикации

4,5-DIPHENYL-PYRIMIDINYLAMINO SUBSTITUTED CARBOXYLIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS

Номер: CA0002651657A1
Принадлежит:

The invention relates to 4,5-diphenyl-pyrimidinyl-amino substituted carbo xylic acids and to their physiologically compatible salts. The invention als o relates to compounds of formula (I), wherein Rl, R2, R3, n, m, V, W, X and Y are defined as cited in the description, and to their physiologically com patible salts. Said compounds are suitable, for example, for the treatment o f diabetes.

Подробнее
10-03-1994 дата публикации

SUBSTITUTED CYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF DISEASES

Номер: CA0002105707A1

Abstract Substituted cyclohexane derivatives for the treatment of diseases Esters of cyclohexane derivatives of the formula I

Подробнее
26-07-2005 дата публикации

CYCLOHEXANE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THE USE OF THE COMPOUNDS FOR THE TREATMENT OF DISEASES

Номер: CA0002149007C
Принадлежит: HOECHST AKTIENGESELLSCHAFT, HOECHST AG

Cyclohexane derivatives of the formula I (see formula I) wherein R2, R4 and R5 have the given meanings and a process for their preparation are described. The compounds have useful pharmacological properties and can therefore be used as pharmaceuticals.

Подробнее
11-11-1995 дата публикации

CYCLOHEXANE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THE USE OF THE COMPOUNDS FOR THE TREATMENT OF DISEASES

Номер: CA0002149007A1

Cyclohexane derivatives of the formula I (see formula I) wherein R2, R4 and R5 have the given meanings and a process for their preparation are described. The compounds have useful pharmacological properties and can therefore be used as pharmaceuticals.

Подробнее
07-01-2004 дата публикации

ADENOSINE ANALOGUES FOR THE TREATMENT OF THE INSULIN RESISTANCE SYNDROME AND DIABETES

Номер: KR20040002962A
Принадлежит:

The invention relates to the use of adenosine compounds described by formula (I) and certain derivatives thereof for producing a medicine for the treatment of the insulin resistance syndrome and diabetes. In formula (I), K is N, NO, or CH; Q is CH2 or O; R6 is hydrogen, alkyl, allyl, 2-methallyl, 2- butenyl, or cycloalkyl; X is (a) or (b); E is O or S; Y is e.g. hydrogen, alkyl, aralkyl, aryl; n and p are independently 0, 1, 2 or 3 provided that n + p is at least 1; T is e.g. hydrogen, alkyl, acyl, thioacyl, halo, carboxyl; R1, R2 and R3 are independently H, alkyl, or cycloalkyl; A is hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl, or OR'; B is hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl, or OR"; R' and R" are e.g independently hydrogen, alkyl, aralkyl or carbamoyl. © KIPO & WIPO 2007 ...

Подробнее
15-01-2009 дата публикации

4,5-DIPHENYL-PYRIMIDINYL SUBSTITUTED CARBOXYLIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS

Номер: KR1020090006847A
Принадлежит:

The invention relates to 4,5-diphenyl-pyrimidinyl substituted carboxylic acids and to their physiologically compatible salts. The invention also relates to compounds of formula (I), wherein Rl, R2, n, m, and X are defined as cited in the description, and to their physiologically compatible salts. Said compounds are suitable, for example, for the treatment of diabetes. © KIPO & WIPO 2009 ...

Подробнее
24-01-2013 дата публикации

Aryloxy-alkylene substituted hydroxyphenyl hexynoic acids, methods for the production thereof and use of the same as medicament

Номер: AU2011281835A1
Принадлежит:

The invention relates to aryloxy-alkylene substituted hydroxyphenyl hexynoic acid derivatives of formula (I) and to their physiologically compatible salts. The compounds are suitable for, for example, the treatment of diabetes, because they cause an increased insulin release by activating the GPR40 receptor.

Подробнее
17-08-1995 дата публикации

SUBSTITUTED CYCLOHEXANOL ESTERS, THEIR USE FOR TREATING DISEASES, AND PHARMACEUTICAL PREPARATIONS

Номер: CA0002142556A1
Принадлежит:

Substituted cyclohexanol esters, their use for treating diseases, and pharmaceutical preparations Cyclohexanol esters of the formula I I are described in which the radicals have the given meaning. The compounds are pharmacologically active and may therefore be used as pharmaceuticals, in particular for treating diabetes and other diseases which are characterized by an elevated secretion of glucose from the liver or by an elevated activity of the glucose-6-phosphatase system.

Подробнее
22-11-2007 дата публикации

PHENYLAMINO-BENZOXAZOLE SUBSTITUTED CARBOXYLIC ACIDS, METHODFOR THEIR PRODUCTION AND USE THEREOF AS MEDICAMENTS

Номер: CA0002651660A1
Принадлежит:

The invention relates to phenylamino-benzoxazole substituted carboxylic a cids and to their physiologically compatible salts. The invention also relat es to compounds of formula (I), wherein R1, R2, R6, R7, R8, R9, R10, m and X are defined as in the description, and to their physiologically compatible salts. Said compounds are suitable, for example, for the treatment of diabet es.

Подробнее
11-04-2013 дата публикации

Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments

Номер: AU2007250213B2
Принадлежит:

The invention relates to phenylamino-benzoxazole substituted carboxylic acids and to their physiologically compatible salts. The invention also relates to compounds of formula (I), wherein R1, R2, R6, R7, R8, R9, R10, m and X are defined as in the description, and to their physiologically compatible salts. Said compounds are suitable, for example, for the treatment of diabetes.

Подробнее
24-01-2013 дата публикации

(2-aryloxy-acetylamino)-phenyl-propionic acid derivatives, method for producing same and use thereof as pharmaceuticals

Номер: AU2011275836A1
Принадлежит:

The invention relates to substituted (2-aryloxy-acetylamino)-phenyl-proprionic acid derivatives of formula I and the physiologically tolerable salts thereof. The compounds are suitable, for example, for treating diabetes, because they effect increased insulin release by activating the GPR40 receptor.

Подробнее
26-02-2009 дата публикации

AZOLORAINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICALS CONTAINING THESE COMPOUNDS, AND THE USE THEREOF

Номер: CA0002696693A1
Принадлежит:

The invention relates to compounds of the formula (I), wherein the residues R, M, W, X, A, B, D, and Y have the stated meanings, and the physiologically compatible salts thereof. The compounds are suitable, for example, for the treatment of the metabolic syndrome, insulin resistance, obesity, and diabetes.

Подробнее
11-09-1995 дата публикации

SUBSTITUTED PROPANE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THE USE OF THE COMPOUNDS FOR TREATING DISEASES

Номер: CA0002144293A1
Принадлежит:

Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases Propane derivatives of the formula I I in which the radicals have the meanings stated in the description, a process for the preparation of these compounds, their use as pharmaceuticals, and pharmaceutical products are described. Also described are novel intermediates for preparing the compounds of the formula I.

Подробнее
16-11-2005 дата публикации

SUBSTITUTED BENZOYLUREIDOPYRIDYL-PIPERIDINE AND -PYRROLIDINE CARBOXYLIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF

Номер: KR1020050108487A
Принадлежит:

The invention relates to substituted benzoylureidopyridyl-piperidine and -pyrrolidine carboxylic acid derivatives, to a method for the production thereof, and to their use. The invention concerns both compounds of formula (I), wherein the radicals have the cited meanings, as well as physiologically compatible salts of said compounds. These compounds are suited for use as, e.g. medicaments for preventing and treating Type 2 diabetes. © KIPO & WIPO 2007 ...

Подробнее
12-08-2004 дата публикации

Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung

Номер: DE0010302452A1
Принадлежит:

Die Erfindung betrifft Verbindungen der Formel I, DOLLAR F1 worin die Reste die angegebenen Bedeutungen haben, sowie deren physiologisch verträgliche Salze. Die Verbindungen eignen sich z. B. als Medikamente zur Prävention und Behandlung von Diabetes Typ 2.

Подробнее
12-01-2012 дата публикации

SPIROCYCLICALLY SUBSTITUTED 1,3-PROPANE DIOXIDE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND USE OF THE SAME AS MEDICAMENT

Номер: CA0002804113A1
Принадлежит:

The invention relates to spirocyclically substituted 1,3-propane dioxide derivatives and to their physiologically compatible salts. The invention relates to compounds of formula (I), in which R1, R2, R3, R4, R5, R6, R7, R8, A and X have the given meanings, and to their physiologically compatible salts. The compounds are suitable for, for example, the treatment of diabetes.

Подробнее
22-11-2007 дата публикации

4,5-DIPHENYL-PYRIMIDINYL-OXY OR -MERCAPTO SUBSTITUTED CARBOXYLIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS

Номер: CA0002651466A1
Принадлежит:

The invention relates to 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids and to their physiologically compatible salts. The invention also relates to compounds of formula (I), wherein Rl, R2, n, m, V, W, X and Y are defined as cited in the description, and to their physiologically compatible salts. Said compounds are suitable, for example, for the treatment of diabetes.

Подробнее
22-11-2007 дата публикации

4,5-DIPHENYL-PYRIMIDINYL SUBSTITUTED CARBOXYLIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS

Номер: CA0002651658A1
Принадлежит:

The invention relates to 4,5-diphenyl-pyrimidinyl substituted carboxylic acids and to their physiologically compatible salts. The invention also rela tes to compounds of formula (I), wherein Rl, R2, n, m, and X are defined as cited in the description, and to their physiologically compatible salts. Sai d compounds are suitable, for example, for the treatment of diabetes. ...

Подробнее
13-11-2008 дата публикации

2-HETEROARYL-PYRROLO[3,4-C]PYRROLE DERIVATIVES AND THEIR USEAS SCD INHIBITORS

Номер: CA0002685543A1
Принадлежит:

The invention relates to compounds of formula (I), in which the groups R1 , M, A, B, D, L and R are defined as cited in the description, and to their physiologically compatible salts. The compounds are suitable e.g. for treati ng metabolic syndrome, insulin resistance, obesity and diabetes.

Подробнее
02-11-2005 дата публикации

CARBONYL-AMINO SUBSTITUTED ACYL PHENYL UREA DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF

Номер: KR1020050104351A
Принадлежит:

The invention relates to compounds of formula (I) wherein the radicals have the cited meaning, in addition to the physiologically compatible salts thereof. The compounds, for example, can be used as medicaments for preventing and treating type 2 diabetes. © KIPO & WIPO 2007 ...

Подробнее
30-06-2005 дата публикации

Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments

Номер: US2005143456A1
Принадлежит:

The invention relates to carboxamide-substituted phenylurea derivatives and their physiologically tolerated salts and physiologically functional derivatives. Compounds of the formula I in which the radicals have the stated meanings, and the physiologically tolerated salts thereof and process for their preparation are described. The compounds are suitable, for example, for treating type II diabetes.

Подробнее
31-07-2008 дата публикации

Verwendung von substituierten Pyranonsäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms

Номер: DE102007002260A1
Принадлежит:

Die Erfindung betrifft die Verwendung von substituierten Pyranonsäurederivaten sowie deren physiologisch verträglichen Salze zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms. Es wird die Verwendung der Verbindungen der Formel I, $F1 worin die Reste die angegebenen Bedeutungen haben, sowie deren physiologisch verträglichen Salze zur Herstellung eines Medikaments zur Behandlung des Metabolischen Syndroms beschrieben.

Подробнее
02-04-2009 дата публикации

(CYCLOPROPYLPHENYL)PHENYLOXALAMIDES, METHOD FOR THE PRODUCTION THEREOF, AND USE OF SAME AS A MEDICAMENT

Номер: CA0002700025A1
Принадлежит:

The invention relates to (cyclopropyl-phenyl)-phenyl-oxalamides and the physiologically compatible salts thereof. The invention also relates to compounds of formula (I), wherein Rl, R2, R3, R4, R5, R6, R7, R8 and m have the cited designations, and to the physiologically compatible salts thereof. The compounds are suitable, for example, for the treatment of diabetes.

Подробнее
24-07-2008 дата публикации

USE OF SUBSTITUTED PYRANONE ACID DERIVATIVES FOR THE TREATMENT OF METABOLIC SYNDROME

Номер: CA0002675442A1

The invention relates to the use of substituted pyranone acid derivatives and their physiologically acceptable salts for producing medicaments for the treatment of metabolic syndrome. The invention also relates to the use of compounds of formula (I), in which the radicals are defined as cited in the description, and their physiologically acceptable salts for producing a medicament for the treatment of metabolic syndrome.

Подробнее
04-11-2005 дата публикации

SUBSTITUTED 3-(BENZOYLUREIDO)-THIOPHENE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF

Номер: KR1020050105470A
Принадлежит:

The invention relates to compounds of formula (I), wherein the radicals have the cited meanings, in addition to the physiologically compatible salts thereof. The compounds can be used, for example, as medicaments in the prevention and treatment of type 2 diabetes. © KIPO & WIPO 2007 ...

Подробнее
15-01-2009 дата публикации

PHENYLAMINO-BENZOXAZOLE SUBSTITUTED CARBOXYLIC ACIDS, METHOD FOR THEIR PRODUCTION AND USE THEREOF AS MEDICAMENTS

Номер: KR1020090006846A
Принадлежит:

The invention relates to phenylamino-benzoxazole substituted carboxylic acids and to their physiologically compatible salts. The invention also relates to compounds of formula (I), wherein R1, R2, R6, R7, R8, R9, R10, m and X are defined as in the description, and to their physiologically compatible salts. Said compounds are suitable, for example, for the treatment of diabetes. © KIPO & WIPO 2009 ...

Подробнее
05-01-2012 дата публикации

HETEROCYCLICALLY SUBSTITUTED METHOXYPHENYL DERIVATIVES WITH AN OXO GROUP, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS

Номер: US20120004165A1
Принадлежит: SANOFI

Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments 2. The compound as claimed in claim 1 , wherein{'sub': 1', '6', '3', '6', '1', '6', '3', '10, 'R1 is H, (C-C)-alkyl, (C-C)-cycloalkyl, (C-C)-alkylene-(C-C)-cycloalkyl, where the alkyl radical, alkylene radical and cycloalkyl radical may be mono- or polysubstituted by fluorine;'}{'sub': 1', '6', '1', '6, 'R2, R10 are each independently H, F, Cl, Br, CN, (C-C)-alkyl, O—(C-C)-alkyl, where the alkyl radical may be mono- or polysubstituted by fluorine;'}X is a bond, —O—, —S—, —(CR7R8)-;{'sub': 1', '2', '3', '4, 'B, B, B, Bare each independently —N— or —C(R9)-;'}{'sub': 1', '6', '3', '10', '1', '6', '3', '10, 'R3, R4, R7, R8 are each independently H, (C-C)-alkyl, (C-C)-cycloalkyl, (C-C)-alkylene-(C-C)-cycloalkyl, where the alkyl radical, alkylene radical and cycloalkyl radical may be mono- or polysubstituted by fluorine;'}{'sub': 2', '1', '6', '1', '6', '2', '3', '2', '2', '2', '1', '6', '2', '1', '6', '2', '2', '1', '6', '1', '6', '2', '5', '6', '10', '3', '10', '1', '6', '6', '10', '3', '10', '3', '1', '6', '1', '6', '5, 'R9 is H, F, Cl, Br, I, OH, NO, CN, O—(C-C)-alkyl, (C-C)-alkyl, SO—CH, SO—NH, SO—NH(C-C)-alkyl, SO—N((C-C)-alkyl), CONH, CONH(C-C)-alkyl, CON((C-C)-alkyl), SF, (C-C)-aryl, (C-C)-cycloalkyl, 4- to 12-membered heterocycle, where the (C-C)-alkyl radical, (C-C)-aryl radical, (C-C)-cycloalkyl radical, 4- to 12-membered heterocycle radical may be mono- or polysubstituted by F, Cl, Br, I, OH, CF, O—(C-C)-alkyl, (C-C)-alkyl, SF;'}n is 0, 1;and physiologically compatible salts thereof.3. The compound as claimed in claim 1 ,wherein{'sub': 1', '6, 'R1 is (C-C)-alkyl, where the alkyl radical may be mono- or polysubstituted by fluorine;'}{'sub': 1', '6', '1', '6, 'R2 is H, F, Cl, Br, CN, (C-C)-alkyl, O—(C-C)-alkyl, where the alkyl radical may be mono- or polysubstituted by fluorine;'}R10 is H;X is a bond, —O—, —S—, —(CR7R8)-;{' ...

Подробнее
05-01-2012 дата публикации

ARYLOXYALKYLENE-SUBSTITUTED HYDROXYPHENYLHEXYNOIC ACIDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT

Номер: US20120004166A1
Принадлежит: SANOFI

The invention relates to aryloxyalkylene-substituted hydroxyphenylhexynoic acid derivatives, and to physiologically compatible salts thereof. 6. (canceled)7. A pharmaceutical composition comprising one or more compounds as claimed in .8. The pharmaceutical composition as claimed in claim 7 , which comprises at least one further active ingredient.9. The pharmaceutical composition as claimed in claim 8 , which comprises claim 8 , as a further active ingredient claim 8 , one or more antidiabetics claim 8 , active hypoglycemic ingredients claim 8 , HMG-CoA reductase inhibitors claim 8 , cholesterol absorption inhibitors claim 8 , PPAR gamma agonists claim 8 , PPAR alpha agonists claim 8 , PPAR alpha/gamma agonists claim 8 , PPAR delta agonists claim 8 , fibrates claim 8 , MTP inhibitors claim 8 , bile acid absorption inhibitors claim 8 , CETP inhibitors claim 8 , polymeric bile acid adsorbers claim 8 , LDL receptor inducers claim 8 , ACAT inhibitors claim 8 , antioxidants claim 8 , lipoprotein lipase inhibitors claim 8 , ATP citrate lyase inhibitors claim 8 , squalene synthetase inhibitors claim 8 , lipoprotein(a) antagonists claim 8 , HM74A receptor agonists claim 8 , lipase inhibitors claim 8 , insulins claim 8 , sulfonylureas claim 8 , biguanides claim 8 , meglitinides claim 8 , thiazolidinediones claim 8 , α-glucosidase inhibitors claim 8 , active ingredients which act on the ATP-dependent potassium channel of the beta cells claim 8 , glycogen phosphorylase inhibitors claim 8 , glucagon receptor antagonists claim 8 , activators of glucokinase claim 8 , inhibitors of gluconeogenesis claim 8 , inhibitors of fructose 1 claim 8 ,6-biphosphatase claim 8 , modulators of glucose transporter 4 claim 8 , inhibitors of glutamine:fructose-6-phosphate amidotransferase claim 8 , inhibitors of dipeptidylpeptidase IV claim 8 , inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 claim 8 , inhibitors of protein tyrosine phosphatase 1B claim 8 , modulators of the sodium-dependent ...

Подробнее
01-09-2005 дата публикации

New 7-phenylamino-quinolone or 1,8-naphthyridone derivatives, useful e.g. for treating type II diabetes or arteriosclerosis, are inhibitors of glycogen phosphorylase

Номер: DE102004004973A1
Принадлежит:

... 7-phenylamino-(aza)-quinolone derivatives (I) and their salts are new. 7-phenylamino-(aza)-quinolone derivatives of formula (I) and their salts are new. R1 : hydroxy or 1-6C alkoxy, optionally substituted by 1-6C alkoxycarbonyl; R2 : hydrogen, 1-6C alkyl or phenyl; R3 : hydrogen, 1-8C alkyl (optionally substituted by R9), 3-7C cycloalkyl, pyridyl or phenyl (both optionally substituted by R10); R9 : amino, (di)1-6C alkylamino, carboxy, 1-6C alkoxycarbonyl, 3-7C cycloalkyl, heteroalkyl, heteroaryl, phenyl or phenoxy, where phenyl and heteroaryl may be substituted by R11; R10 : fluoro, chloro, bromo, 1-6C alkyl or alkoxy, carboxy, 1-6C alkoxycarbonyl, amino or (di)1-6C alkylamino; R11 : fluoro, chloro, 1-6C alkyl or alkoxy, amino, (di)1-6C alkylamino, carboxy or 1-4C alkoxycarbonyl; X : CR4 or N; R4 and R5 : hydrogen, floro, chloro, bromo, hydroxy, nitro, cyano, 1-6C alkyl or alkoxy, where alkyl may be substituted by chloro, fluoro or bromo; R6 : R4 but not hydroxy; R7 : hydrogen or 1-6C alkyl ...

Подробнее
16-05-2013 дата публикации

(Cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament

Номер: AU2008303975B2
Принадлежит:

The invention relates to (cyclopropyl-phenyl)-phenyl-oxalamides and the physiologically compatible salts thereof. The invention also relates to compounds of formula (I), wherein Rl, R2, R3, R4, R5, R6, R7, R8 and m have the cited designations, and to the physiologically compatible salts thereof. The compounds are suitable, for example, for the treatment of diabetes.

Подробнее
02-04-2009 дата публикации

(CARBOXYLALKYLENEPHENYL)PHENYLOXALAMIDES, METHOD FOR THE PRODUCTION THEREOF AND USE OF SAME AS A MEDICAMENT

Номер: CA0002700028A1
Принадлежит:

The invention relates to bis-phenyl-oxalamides and the physiologically compatible salts thereof. The invention also relates to compounds of formula (I), wherein Rl, R2, R3, R4, R5, R6, R7, R8, m and X have the cited designations, and to the physiologically compatible salts thereof. The compounds are suitable, for example, for the treatment of diabetes.

Подробнее
23-01-2003 дата публикации

ACYLPHENYL UREA DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND USE THEREOF AS A MEDICAMENT

Номер: KR20030007934A
Принадлежит:

The invention relates to acylphenyl urea derivatives and the physiologically compatible salts and physiologically functional derivatives thereof. Such compounds correspond to the formula (I) wherein the radicals have the cited meanings. The invention also relates to a method for producing said compounds. Said compounds can be used, for example, for treating Type II diabetes. © KIPO & WIPO 2007 ...

Подробнее
16-01-2009 дата публикации

4,5-DIPHENYL-PYRIMIDINYL-OXY OR-MERCAPTO SUBSTITUTED CARBOXYLIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS

Номер: KR1020090007413A
Принадлежит:

The invention relates to 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids and to their physiologically compatible salts. The invention also relates to compounds of formula (I), wherein Rl, R2, n, m, V, W, X and Y are defined as cited in the description, and to their physiologically compatible salts. Said compounds are suitable, for example, for the treatment of diabetes. © KIPO & WIPO 2009 ...

Подробнее
14-03-2005 дата публикации

HETEROCYCLICALLY SUBSTITUTED BENZOYLUREAS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS

Номер: KR1020050025345A
Принадлежит:

The invention relates to heterocyclically substituted benzoylureas, in addition to their physiologically compatible salts and physiologically functional derivatives. The invention relates in particular to compounds of formula (I), in which the groups are defined as cited in the description, in addition to their physiologically compatible salts and to a method for producing said compounds. The compounds are suitable e.g. for treating type 2 diabetes. © KIPO & WIPO 2007 ...

Подробнее
01-04-2008 дата публикации

4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, process for their preparation and their use as pharmaceuticals

Номер: TW0200815367A
Принадлежит:

The invention relates to 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids and to their physiologically compatible salts. The invention relates to compounds of the formula I, in which R1, R2, R3, n, m, V, W, X and Y have the stated meanings, and their physiologically tolerated salts. The compounds are suitable for example for the treatment of diabetes.

Подробнее
26-01-2012 дата публикации

ARYLOXYALKYLENE-SUBSTITUTED HYDROXYPHENYLHEXYNOIC ACIDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT

Номер: CA0002804110A1
Принадлежит:

The invention relates to aryloxy-alkylene substituted hydroxyphenyl hexynoic acid derivatives of formula (I) and to their physiologically compatible salts. The compounds are suitable for, for example, the treatment of diabetes, because they cause an increased insulin release by activating the GPR40 receptor.

Подробнее
07-09-2004 дата публикации

SUBSTITUTED CYCLOHEXANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THE USE OF THE COMPOUNDS FOR TREATING DISEASES

Номер: CA0002105709C
Принадлежит: HOECHST AKTIENGESELLSCHAFT, HOECHST AG

Substituted cyclohexane derivatives, processes for their preparation, and the use of the compounds for treating diseases Cyclohexane derivatives of the formula I (See Formula I) in which R1 is CN, COOH, C1-C4-alkanoyl, SO3-C1-C4-alkyl, SO3H or SO2NR8R9; R2 is C1-C10-alkyl(R11)n, O-C1-C10- alkyl(R11)n, C2-C10-alkenyl(R11)n, O-C3-C10-alkenyl(R11)n, C2- C10-alkynyl(R11)n, O-C3-C10-alkynyl(R11)n, S-C1-C10-alkyl(R11)n, S-C3-C10-alkenyl(R11)n, S-C3-C10-alkynyl(R11)n, NH-C1-C10- alkyl(R11)n, NH-C3-C10-alkenyl(R11)n, or NH-C3-C10- alkynyl(R11)n, where R11 is unsubstituted or substituted in each case by R12; R3 is unsubstituted or substituted indolyl, imidazolyl, benzimidazolyl, quinolyl or tetrazolyl; R11 and R13 are identical or different and are alkyl with 1 to 10 carbon atoms, cycloalkyl with 3-8 ring carbon atoms, or unsubsituted or substituted phenyl, naphthyl, phenanthryl, thienyl, furyl or coumarinyl; R4. R5 and R6 are identical or different and are H, OH, a protected OH group, F, Cl or ...

Подробнее
15-11-1997 дата публикации

SULFONAMIDE-SUBSTITUTED CHROMANS, PROCESSES FOR THEIR PREPARATION, THEIR USE AS A MEDICAMENT OR DIAGNOSTIC, AND MEDICAMENT COMPRISING THEM

Номер: CA0002205477A1
Принадлежит:

Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or a diagnostic, and medicament comprising them Chromans of the formula I I and of the formula 1 a 1 a having the meanings R(A), R(B), R(C) and R(1) to R(8) indicated in the claims are outstandingly suitable for preparing a medicament for blocking the K+ channel which is opened by cyclic adenosine monophosphate (cAMP); and further for preparing a medicament for inhibiting gastric acid secretion; for the treatment of ulcers of the stomach and of the intestinal region, in particular of the duodenum, for the treatment of reflux esophagitis, for the treatment of diarrheal illnesses, for the treatment and prevention of all types of arrhythmias including ventricular and supraventricular arrhythmias, and for the control of reentry arrhythmias and for the prevention of sudden heart death as a result of ventricular fibrillation.

Подробнее
30-01-2013 дата публикации

SPIROCYCLICALLY SUBSTITUTED 1,3-PROPANE DIOXIDE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND USE OF THE SAME AS MEDICAMENT

Номер: SG0000186405A1
Принадлежит: SANOFI SA, SANOFI

The invention relates to spirocyclically substituted 1,3-propane dioxide derivatives and to their physiologically compatible salts. The invention relates to compounds of formula (I), in which R1, R2, R3, R4, R5, R6, R7, R8, A and X have the given meanings, and to their physiologically compatible salts. The compounds are suitable for, for example, the treatment of diabetes.

Подробнее
12-01-2012 дата публикации

(2-ARYLOXY-ACETYLAMINO)-PHENYL-PROPIONIC ACID DERIVATIVES, METHOD FOR PRODUCING SAME AND USE THEREOF AS PHARMACEUTICALS

Номер: CA0002804112A1
Принадлежит: SANOFI SA

The invention relates to substituted (2-aryloxy-acetylamino)-phenyl-proprionic acid derivatives of formula I and the physiologically tolerable salts thereof. The compounds are suitable, for example, for treating diabetes, because they effect increased insulin release by activating the GPR40 receptor.

Подробнее
10-03-1994 дата публикации

SUBSTITUTED CYCLOHEXANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THE USE OF THE COMPOUNDS FOR TREATING DISEASES

Номер: CA0002105709A1
Принадлежит:

... of the disclosure Substituted cyclohexane derivatives, processes for their preparation, and the use of the compounds for treating diseases Cyclohexane derivatives of the formula I I in which the radicals R1 to R6, X, Y and Z have the stated meanings, and processes for the preparation of these compounds are described. The compounds have valuable pharmacological properties and can therefore be used as pharmaceuticals.

Подробнее
18-08-2005 дата публикации

7-phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments

Номер: US2005182085A1
Принадлежит:

... 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments The invention relates to 7-phenylamino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. The invention relates to compounds of the formula I in which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.

Подробнее
09-01-2007 дата публикации

SUBSTITUTED PROPANE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THE USE OF THE COMPOUNDS FOR TREATING DISEASES

Номер: CA0002144293C
Принадлежит: HOECHST AKTIENGESELLSCHAFT, HOECHST AG

Propane derivatives of the formula I (see formula I) in which the radicals have the meanings stated in the description, a process for the preparation of these compounds, their use as pharmaceuticals, and pharmaceutical products are described. Also described are novel intermediates for preparing the compounds of the formula I.

Подробнее
10-09-2013 дата публикации

Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments

Номер: US0008530413B2

Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments The invention relates to heterocyclically substituted methoxyphenyl derivatives with an oxo group, and to physiologically compatible salts thereof. The invention relates to compounds of the formula I in which R1, R2, R3, R4, R10, X, n, B 1 , B 2 , B 3 and B 4 are each defined as specified, and to the physiologically compatible salts thereof. The compounds are suitable, for example, for treatment of diabetes.

Подробнее
30-12-2008 дата публикации

Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments

Номер: US0007470706B2

The invention relates to cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. The invention relates to compounds of the formula I in which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.

Подробнее
02-12-2004 дата публикации

Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung

Номер: DE0010309929A1
Принадлежит:

Die Erfindung betrifft Verbindungen der Formel I, DOLLAR F1 worin die Reste die angegebenen Bedeutungen haben, sowie deren physiologisch verträgliche Salze. Die Verbindungen eignen sich z. B. als Medikamente zur Prävention und Behandlung von Diabetes Typ 2.

Подробнее
05-01-2012 дата публикации

(2-ARYLOXYACETYLAMINO) PHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS

Номер: US20120004167A1
Принадлежит: SANOFI

The invention relates to substituted (2-aryloxyacetylamino)phenylpropionic acid derivatives, and to the physiologically acceptable salts thereof. 6. (canceled)7. A pharmaceutical composition comprising one or more compounds as claimed in .8. The pharmaceutical composition as claimed in claim 7 , which comprises at least one further active ingredient.9. The pharmaceutical composition as claimed in claim 8 , which comprises claim 8 , as a further active ingredient claim 8 , one or more antidiabetics claim 8 , active hypoglycemic ingredients claim 8 , HMG-CoA reductase inhibitors claim 8 , cholesterol absorption inhibitors claim 8 , PPAR gamma agonists claim 8 , PPAR alpha agonists claim 8 , PPAR alpha/gamma agonists claim 8 , PPAR delta agonists claim 8 , fibrates claim 8 , MTP inhibitors claim 8 , bile acid absorption inhibitors claim 8 , CETP inhibitors claim 8 , polymeric bile acid adsorbers claim 8 , LDL receptor inducers claim 8 , ACAT inhibitors claim 8 , antioxidants claim 8 , lipoprotein lipase inhibitors claim 8 , ATP citrate lyase inhibitors claim 8 , squalene synthetase inhibitors claim 8 , lipoprotein(a) antagonists claim 8 , HM74A receptor agonists claim 8 , lipase inhibitors claim 8 , insulins claim 8 , sulfonylureas claim 8 , biguanides claim 8 , meglitinides claim 8 , thiazolidinediones claim 8 , α-glucosidase inhibitors claim 8 , active ingredients which act on the ATP-dependent potassium channel of the beta cells claim 8 , glycogen phosphorylase inhibitors claim 8 , glucagon receptor antagonists claim 8 , activators of glucokinase claim 8 , inhibitors of gluconeogenesis claim 8 , inhibitors of fructose 1 claim 8 ,6-biphosphatase claim 8 , modulators of glucose transporter 4 claim 8 , inhibitors of glutamine fructose-6-phosphate amidotransferase claim 8 , inhibitors of dipeptidylpeptidase IV claim 8 , inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 claim 8 , inhibitors of protein tyrosine phosphatase 1B claim 8 , modulators of the sodium- ...

Подробнее
04-07-2013 дата публикации

3-[4-(PHENYLAMINOOXALYLAMINO)PHENYL]HEX-4-YNOIC ACIDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT

Номер: US20130172248A1
Принадлежит:

The invention relates to 3-[4-(phenylaminooxalylamino)phenyl]hex-4-ynoic acids, and to physiologically compatible salts thereof. 2. A compound as claimed in claim 1 , wherein{'sub': '3', 'R1 is H, F, CH;'}{'sub': '3', 'R2 is F, CH;'}{'sub': '3', 'R3 is F, CH;'}{'sub': 3', '3, 'R4 is H, Cl, CH, CF;'}and physiologically compatible salts thereof.9. (canceled)10. A pharmaceutical composition comprising the compound of claim 1 , and a pharmaceutically acceptable carrier.11. The pharmaceutical composition as claimed in claim 10 , which comprises at least one further active ingredient.12. The pharmaceutical composition as claimed in claim 11 , which comprises claim 11 , as a further active ingredient claim 11 , one or more antidiabetics claim 11 , active hypoglycemic ingredients claim 11 , HMG-CoA reductase inhibitors claim 11 , cholesterol absorption inhibitors claim 11 , PPAR gamma agonists claim 11 , PPAR alpha agonists claim 11 , PPAR alpha/gamma agonists claim 11 , PPAR delta agonists claim 11 , fibrates claim 11 , MTP inhibitors claim 11 , bile acid absorption inhibitors claim 11 , CETP inhibitors claim 11 , polymeric bile acid adsorbers claim 11 , LDL receptor inducers claim 11 , ACAT inhibitors claim 11 , antioxidants claim 11 , lipoprotein lipase inhibitors claim 11 , ATP citrate lyase inhibitors claim 11 , squalene synthetase inhibitors claim 11 , lipoprotein(a) antagonists claim 11 , HM74A receptor agonists claim 11 , lipase inhibitors claim 11 , insulins claim 11 , sulfonylureas claim 11 , biguanides claim 11 , meglitinides claim 11 , thiazolidinediones claim 11 , alpha-glucosidase inhibitors claim 11 , active ingredients which act on the ATP-dependent potassium channel of the beta cells claim 11 , glycogen phosphorylase inhibitors claim 11 , glucagon receptor antagonists claim 11 , activators of glucokinase claim 11 , inhibitors of gluconeogenesis claim 11 , inhibitors of fructose 1 claim 11 ,6-biphosphatase claim 11 , modulators of glucose transporter 4 claim ...

Подробнее
05-09-2013 дата публикации

(CARBOXYLALKYLENEPHENYL)PHENYLOXAMIDES, METHOD FOR THE PRODUCTION THEREOF AND USE OF SAME AS A MEDICAMENT

Номер: US20130231388A1
Принадлежит: SANOFI

The invention relates to (carboxylalkylenephenyl)phenyloxamides and their physiologically tolerated salts, and their use as a medicament. 118-. (canceled)20. (canceled) The invention relates to (carboxylalkylenephenyl)phenyloxamides and their physiologically tolerated salts.Compounds of similar structure have been described in the prior art (see US2005/0124667), as well as the use thereof as antithrombotics.The invention was based on the object of providing compounds which display a therapeutically useful effect. The object was in particular to find novel compounds suitable for the treatment of hyperglycemia and diabetes.The invention therefore relates to compounds of the formula Iin which the meanings arePreference is given to compounds of the formula I in which one or more radicals have the following meanings:Particular preference is given to compounds of the formula I in which one or more radicals have the following meanings:Particular preference is further given to compounds of the formula I in which one or more radicals have the following meanings:In a further embodiment, preference is given to compounds of the formula I in which one or more radicals have the following meanings:In a further embodiment, preference is given to compounds of the formula I in which one or more radicals have the following meanings:In a further embodiment, preference is given to compounds of the formula I in which one or more radicals have the following meanings:In a further embodiment, preference is given to compounds of the formula I in which one or more radicals have the following meanings:Compounds of the formula I preferred in one embodiment are those in which X is —(CH).Compounds of the formula I preferred in one embodiment are those in which X is —(CH)—.Compounds of the formula I preferred in one embodiment are those in which the group —X—COOH is linked in position 3 to the ring.Compounds of the formula I preferred in one embodiment are those in which the group —X—COOH is ...

Подробнее
04-02-2003 дата публикации

Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion

Номер: PE20021091A1
Принадлежит: Aventis Pharma Gmbh

SE REFIERE A DERIVADOS DE FENILUREA SUSTITUIDOS CON CARBONAMIDA DE FORMULA I DONDE A ES FENILO, NAFTILO CON F, Cl, Br, ENTRE OTROS; R1 Y R2 SON H, ALQUILO C1-C6, O-ALQUILO C1-C6, CO-ALQUILO (C1-C6), ENTRE OTROS, R3, R4, R5, R6 ES H, F, Cl, Br, OH, CF3, NO2, ENTRE OTROS; R7 ES H, ALQUILO C1-C6, CO-ALQUILO (C1-C6); R8 ES H, ALQUILO C1-C10 CON OH, CF3, CN, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION

Подробнее
29-12-2011 дата публикации

Heterocyclic substituted methoxyphenyl derivatives having an oxo group, method for producing same, and use thereof as gpr40 receptor modulators

Номер: WO2011161030A1
Принадлежит: SANOFI

The invention relates to heterocyclic substituted methoxyphenyl derivatives having an oxo group, and to the physiologically compatible salts thereof. The invention relates to compounds of formula (I), where R1, R2, R3, R4, R10, X, n, B1, B2, B3 und B4 have the meanings indicated, and to the physiologically compatible salts thereof. The compounds are suitable, for example, for treating diabetes.

Подробнее
12-01-2012 дата публикации

(2-aryloxy-acetylamino)-phenyl-propionic acid derivatives, method for producing same and use thereof as pharmaceuticals

Номер: WO2012004269A1
Принадлежит: SANOFI

The invention relates to substituted (2-aryloxy-acetylamino)-phenyl-proprionic acid derivatives of formula I and the physiologically tolerable salts thereof. The compounds are suitable, for example, for treating diabetes, because they effect increased insulin release by activating the GPR40 receptor.

Подробнее
12-01-2012 дата публикации

Spirocyclically substituted 1,3-propane dioxide derivatives, methods for the production thereof and use of the same as medicament

Номер: WO2012004270A1
Принадлежит: SANOFI

The invention relates to spirocyclically substituted 1,3-propane dioxide derivatives and to their physiologically compatible salts. The invention relates to compounds of formula (I), in which R1, R2, R3, R4, R5, R6, R7, R8, A and X have the given meanings, and to their physiologically compatible salts. The compounds are suitable for, for example, the treatment of diabetes.

Подробнее
26-01-2012 дата публикации

Aryloxy-alkylene substituted hydroxyphenyl hexynoic acids, methods for the production thereof and use of the same as medicament

Номер: WO2012010413A1
Принадлежит: SANOFI

The invention relates to aryloxy-alkylene substituted hydroxyphenyl hexynoic acid derivatives of formula (I) and to their physiologically compatible salts. The compounds are suitable for, for example, the treatment of diabetes, because they cause an increased insulin release by activating the GPR40 receptor.

Подробнее
15-11-2007 дата публикации

Phenylamino-benzoxazole substituted carboxylic acids, process for their preparation and their use as medicaments

Номер: DE102006021878A1
Принадлежит: Sanofi Aventis France

Die Erfindung betrifft Phenylamino-benzoxazol substituierte Carbonsäuren sowie deren physiologisch verträgliche Salze. Die Erfindung betrifft Verbindungen der Formel I, $F1 worin R1, R2, R6, R7, R8, R9, R10, m und X die angegebenen Bedeutungen haben, sowie deren physiologisch verträgliche Salze. Die Verbindungen eignen sich z. B. zur Behandlung des Diabetes. The invention relates to phenylamino-benzoxazole substituted carboxylic acids and their physiologically acceptable salts. The invention relates to compounds of the formula I, wherein each of R 1, R 2, R 6, R 7, R 8, R 9, R 10, m and X has the meanings indicated, and their physiologically tolerable salts. The compounds are suitable for. B. for the treatment of diabetes.

Подробнее
01-05-1990 дата публикации

2-(2-picolylsulfur)-trienoimidazole derivatives

Номер: CA1268461A
Принадлежит: Hoechst AG

Abstract of the disclosure: Substituted thienoimidazole derivatives, processes for their preparation,pharmaceutical formulations containing them and their use as gastric acid secretion inhibitors. The invention relates to compounds of the formula I (I) in which A stands for (a) , (b) or (c)

Подробнее
03-10-1989 дата публикации

Substituted thienoimidazole-toluidine derivatives as inhibitors of gastric acid secretion

Номер: US4871734A
Принадлежит: Hoechst AG

Thienoimidazole-toluidines of the formula I ##STR1## in which A represents ##STR2## T denotes --S--, --SO-- or --SO 2 --, and R 1 to R 9 have the meanings stated in the description, and a process for their preparation, pharmaceutical compositions containing them, and their use as inhibitors of gastric acid secretion, are described.

Подробнее
22-06-1988 дата публикации

Substituted thienoimidazotoluidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use as gastric-acid secretion inhibitors

Номер: EP0271733A2
Принадлежит: Hoechst AG

Thienoimidazoltoluidine der Formel I <IMAGE> worin A für <IMAGE> steht, T -S-, -SO- oder -SO2- bedeutet und R¹ bis R<8> die in der Beschreibung angegebenen Bedeutungen haben sowie ein Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Magensäuresekretionshemmer werden beschrieben. Thienoimidazoltoluidines of the formula I <IMAGE> in which A is <IMAGE>, T is -S-, -SO- or -SO2- and R¹ to R <8> have the meanings given in the description and a process for their preparation, they containing pharmaceutical preparations and their use as gastric acid secretion inhibitors are described.

Подробнее
14-12-2005 дата публикации

Substituted benzoylureidopyridyl-piperidine and -pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof

Номер: EP1603895A1
Принадлежит: Sanofi Aventis Deutschland GmbH

The invention relates to substituted benzoylureidopyridyl-piperidine and -pyrrolidine carboxylic acid derivatives, to a method for the production thereof, and to their use. The invention concerns both compounds of formula (I), wherein the radicals have the cited meanings, as well as physiologically compatible salts of said compounds. These compounds are suited for use as, e.g. medicaments for preventing and treating Type 2 diabetes.

Подробнее
07-04-2004 дата публикации

Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes

Номер: EP1404338A1
Принадлежит: Aventis Pharma Deutschland GmbH

The invention relates to the use of adenosine compounds described by formula (I) and certain derivatives thereof for producing a medicine for the treatment of the insulin resistance syndrome and diabetes. In formula (I), K is N, NO, or CH; Q is CH2 or O; R6 is hydrogen, alkyl, allyl, 2-methallyl, 2-butenyl, or cycloalkyl; X is (a) or (b); E is O or S; Y is e.g. hydrogen, alkyl, aralkyl, aryl; n and p are independently 0, 1, 2 or 3 provided that n + p is at least 1; T is e.g. hydrogen, alkyl, acyl, thioacyl, halo, carboxyl; R1, R2 and R3 are independently H, alkyl, or cycloalkyl; A is hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl, or OR'; B is hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl, or OR'; R' and R' are e.g independently hydrogen, alkyl, aralkyl or carbamoyl.

Подробнее
11-08-2005 дата публикации

7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments

Номер: CA2554522A1

The invention relates to 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, the physiologically-acceptable salts and physiologically-functional derivatives thereof, also compounds of formula (I), where the groups have the given meanings and the physiologically-acceptable salts thereof. Said compound are suitable for use, for example, as medicaments for the prevention and treatment of type 2 diabetes.

Подробнее
04-09-2003 дата публикации

New N-aroyl-N'-(carbamoyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibiting hypoglycemic agents, especially useful for treating type II diabetes

Номер: DE10207369A1
Принадлежит: Aventis Pharma Deutschland GmbH

N-(Benzoyl or naphthoyl)-N'-(carbamoyl-phenyl)-urea derivatives (I) are new. Phenylurea derivatives of formula (I) and their salts are new. A = phenyl or naphthyl (both optionally substituted (os) by 1-3 of F, Cl, Br, OH, CF3, NO2, CN, OCF3, alkoxy, alkenyloxy, alkynyloxy, alkylthio, alkenylthio, alkynylthio, alkylsulfinyl, alkylsulfonyl, SO2NH2, alkyl, alkenyl, alkynyl, 3-7C cycloalkyl, (3-7C) cycloalkyl-(1-4C) alkyl, COOH, carboxyalkyl, (1-7C) alkoxycarbonyl, (1-7C) alkoxycarbonylalkyl, (2-7C) alkenyloxycarbonyl, (2-7C) alkenyloxycarbonylalkyl, CONH2, mono- or dialkylcarbamoyl, (3-6C) cycloalkylcarbamoyl, NH2, aminoalkyl, mono- or dialkylamino, mono- or dialkylaminoalkyl, alkylcarbonylamino, NHCOPh' or NHSO2Ph'); Ph' = phenyl (os by 1 or 2 of F, Cl, CN, OH, alkyl, alkoxy, CF3, OCF3, COOH, alkoxycarbonyl or CONH2); R1, R2 = H, alkyl, alkoxy, alkylcarbonyl or alkoxycarbonyl; R3 - R6 = H, F, Cl, Br, OH, CF3, NO2, CN, OCF3, alkoxy, alkenyloxy, alkynyloxy, alkylthio, alkenylthio, alkynylthio, alkylsulfinyl, alkylsulfonyl, SO2NH2, alkyl, alkenyl, alkynyl, 3-7C cycloalkyl, (3-7C) cycloalkyl-(1-4C) alkyl, COOH, (1-7C) alkoxycarbonyl, CONH2, mono- or dialkylcarbamoyl, (3-7C) cycloalkylcarbamoyl, NH2, mono- or dialkylamino, alkylcarbonylamino, NHCOPh' or NHSO2Ph'; R7 = H, alkyl or alkylcarbonyl; R8 = H; 1-10C alkyl (os by 1-3 of OH, CF3, CN, COOH, alkoxycarbonyl, CONH2, NH2, mono- or dialkylamino, NCO-alkyl, NCOO-alkyl, NCOO-(1-6C) alkenyl (sic), NCOO-(1-6C) alkynyl (sic) or NCOO-(1-4C) alkylene-(6-10C) aryl or -(CH2)m-Ar; m = 0-6; Ar = phenyl, phenoxy, benzoyl, benzo (1,3) dioxolyl, heterocycloalkyl, pyridyl, indolyl, piperidinyl, tetrahydronapthyl, 2,3-dihydro-benzo (1,4) dioxinyl, benzo (1,2,5) thiadiazolyl, pyrrolidinyl or morpholinyl (all os by one or more R9); and R9 = F, Cl, Br, OH, NO2, CF3, OCF3, alkyl, hydroxyalkyl, alkoxy, alkylthio, (1-4C) alkyl-phenyl, COOH or alkoxycarbonyl. unless specified otherwise alkyl groups have 1-6C and alkenyl ...

Подробнее
28-02-2013 дата публикации

Aryloxy-alkylene substituted hydroxyphenyl hexynoic acids, methods for the production thereof and use of the same as medicament

Номер: SG186771A1
Принадлежит: SANOFI SA

The invention relates to aryloxy-alkylene substituted hydroxyphenyl hexynoic acid derivatives of formula (I) and to their physiologically compatible salts. The compounds are suitable for, for example, the treatment of diabetes, because they cause an increased insulin release by activating the GPR40 receptor.

Подробнее
29-11-2006 дата публикации

Substituted benzoylureidopyridyl-piperidine and pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof

Номер: ZA200506119B
Принадлежит: Aventis Pharma Gmbh

The invention relates to substituted benzoylureidopyridyl-piperidine and -pyrrolidine carboxylic acid derivatives, to a method for the production thereof, and to their use. The invention concerns both compounds of formula (I), wherein the radicals have the cited meanings, as well as physiologically compatible salts of said compounds. These compounds are suited for use as, e.g. medicaments for preventing and treating Type 2 diabetes.

Подробнее
20-11-2003 дата публикации

Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use

Номер: US20030216370A1
Принадлежит: Aventis Pharma Deutschland GmbH

The invention relates to acyl-3-carboxyphenylurea derivatives and to their physiologically tolerated salts and physiologically functional derivatives. The invention relates to compounds of formula I, in which the radicals have the given meanings, and to their physiologically tolerated salts and processes for preparing them. The compounds are, for example, suitable for use as antidiabetics.

Подробнее
13-09-1995 дата публикации

Substituted propane derivatives, process for their preparation and use of the compounds for the treatment of illnesses

Номер: EP0671392A1
Принадлежит: Hoechst AG

Propane derivs. of formula (I), and their salts, are new: D-B-A = opt. substd. propyl, omega -hydroxy- (1-4C)alkyl, OH, OT, phenyl or phenyl(1-3C)alkyl); R<1> = CN, COOH (opt. protected), 1-4C alkanoyl, SO3T, SO3H, SO2NR<5>R<6>, PO(OH)2, PO(OH)(OT), PO(OT)2 or tetrazol-5-yl; R<2> = 1-10C alkyl(R<8>)n, O-(1-10C)alkyl(R<8>)n, 2-10C alkenyl(R<8>)n, O-(3-10C)alkenyl(R<8>)n, 2-10C alkynyl(R<8>)n, O-(3-10C)alkynyl(R<8>)n, S-(1-10C)alkyl(R<8>)n, etc. (all R<8> gps. being opt. substd.); R<5>, R<6> = H, T, 1-4C alkanoyl or opt. substd. phenyl; or NR<5>R<6> = a 4-10 membered, satd. heterocyclic ring (in which one CH2 gp. is opt. replaced by O, S or NR<7>); R<7> = H, T, phenyl or benzyl; X = (CH2)m, CH=CH, C IDENTICAL C, CH2OCH2, CH2SCH2 or CH2-N(R<5>)-CH2; Y = (CH2)m, O, S or NR<5>; Z = (CH2)m, S, O, S-(1-10C)alkyl, O-(1-10C)alkyl, CH=CH, CH=CF, CH=CCl, CH=CBr, CH2CO, etc.; or when Y = O, the gp. C(O)ZR<3> may be an opt. protected amino acid residue; n = 0, 1 or 2; m = 0-4; R<3>, R<8> = 1-10C alkyl, 3-8C cycloalkyl, or opt. substd. Ar; T = 1-4C alkyl; Ar = phenyl, naphthyl, phenanthryl, pyridyl, thienyl, furyl, pyrimidyl, indolyl, etc.

Подробнее
22-08-1986 дата публикации

PROCEDURE FOR THE PREPARATION OF SUBSTITUTED TOLUIDINES.

Номер: NO863389D0
Принадлежит: Hoechst AG

Подробнее
11-02-2014 дата публикации

(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments

Номер: US8648038B2
Принадлежит: SANOFI SA

The invention relates to substituted (2-aryloxyacetylamino)phenylpropionic acid derivatives, and to the physiologically acceptable salts thereof. The invention relates to compounds of the formula I in which R1, R2, R3, R4, R5, R6, R7, R8, R9 and A are each defined as specified, and the physiologically compatible salts thereof. The compounds are suitable, for example, for treatment of diabetes.

Подробнее
16-05-1988 дата публикации

Substituted toluidines, process for their preparation, pharmaceutical compositions containing them and their use as gastric secretion inhibitors.

Номер: ES2001389A6
Принадлежит: Hoechst AG

o-Toluidine derivatives of the formula I < IMAGE > in which A denotes S, SO or SO2 and R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, R<7>, R<8>, R<1><3>, R<1><4> and R<1><5> represent hydrogen and/or defined substituents.

Подробнее
21-03-1994 дата публикации

Substituted cyclohexane derivatives for treating diseases

Номер: PL300328A1
Принадлежит: Hoechst AG

Подробнее
02-09-1987 дата публикации

Substituted thienoimidazole derivatives, processes for their production, pharmaceutical compositions containing them and their use as gastric secretion inhibitors

Номер: EP0234485A1
Принадлежит: Hoechst AG

Die Erfindung betrifft Verbindungen der Formel <IMAGE> R¹ bis R<9> die in der Beschreibung angegebenen Bedeutungen haben, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Magensäuresekretionshemmer. The invention relates to compounds of the formula <IMAGE> R¹ to R <9> which have the meanings given in the description, processes for their preparation, pharmaceutical preparations containing them and their use as gastric acid secretion inhibitors.

Подробнее
04-01-2010 дата публикации

The use of acid-derivative pyronone derivatives to treat metabolic syndrome.

Номер: MA31094B1
Принадлежит: Sanofi Aventis

L'invention concerne l'utilisation de dérivés acides de pyranone substitués et de leurs sels physiologiquement tolérables dans la production de médicaments destinés au traitement du syndrome métabolique. L'invention concerne en particulier l'utilisation des composés de formule (i), dans laquelle les groupes ont les significations indiquées, ainsi que de leur sels physiologiquement tolérables dans la production d'un médicament destiné au traitement du syndrome métabolique. The invention relates to the use of substituted pyranone acid derivatives and their physiologically tolerable salts in the production of medicaments for the treatment of metabolic syndrome. The invention relates in particular to the use of the compounds of formula (i), in which the groups have the indicated meanings, as well as their physiologically tolerable salts in the production of a medicament for the treatment of the metabolic syndrome.

Подробнее
19-04-2007 дата публикации

Carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives and their use as medicaments

Номер: US20070088083A1
Принадлежит: Sanofi Aventis Deutschland GmbH

The invention relates to acyl-carboxyphenylurea derivatives and to their physiologically tolerated salts and physiologically functional derivatives. Compounds of the formula I, in which the radicals have the stated meanings, and the physiological tolerated salts thereof and processes for preparing them are described. The compounds are suitable for example for the treatment of type II diabetes.

Подробнее
06-02-2009 дата публикации

4,5-diphenyl-pyrimidinyl-amino-substituted carboxylic acids, process for their preparation and use thereof as medicaments

Номер: NO20085066L
Принадлежит: Sanofi Aventis

Det beskrives 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer og deres fysiologisk kompatible salter. Det beskrives videre forbindelser med formel (I), der RI, R2, R3, n, m, V, W, X og Y er som angitt i beskrivelsen samt deres fysiologisk kompatible salter. Forbindelsene er for eksempel egnede for behandling av diabetes.

Подробнее
01-11-2011 дата публикации

4,5-diphenyl pyrimidinyl substituted carboxylic acids, process for their production and use as medicaments

Номер: BRPI0711416A2
Принадлежит: Sanofi Aventis

CIDOS CARBOXìLICOS SUBSTITUIDOS COM 4,5-DIFENIL PIRIMIDINILA, PROCESSO PARA A PRODUçãO E USO DOS MESMOS COMO MEDICAMENTOS. A presente invenção refere-se a ácidos carboxílicos substituidos com 4,5-difenil pirimidinila e seus sais fisiologicamente tolerados. A invenção também refere-se a compostos de fórmula 1, na qual Ri, R2, n, m e X são definidos conforme o relatório descritivo, e a seus sais fisiologicamente tolerados. Tais compostos são adequados, por exemplo, para o tratamento de diabetes.  CARBOXYLIC CIDES REPLACED WITH 4,5-DIPHENYL PYRIMIDINYL, PROCESS FOR THE PRODUCTION AND USE OF THEM AS MEDICINES. The present invention relates to 4,5-diphenyl pyrimidinyl substituted carboxylic acids and their physiologically tolerated salts. The invention also relates to compounds of formula 1, in which Ri, R2, n, m and X are defined according to the specification, and their physiologically tolerated salts. Such compounds are suitable, for example, for the treatment of diabetes.

Подробнее
07-01-2010 дата публикации

Use of substituted pyridinone carboxylic acid derivates for producing pharmaceuticals for the treatment of dyslipidemia

Номер: WO2010000401A1
Принадлежит: SANOFI-AVENTIS

The invention relates to the use of substituted pyridinone carboxylic acid derivates and the physiologically acceptable salts thereof for the production of pharmaceuticals for treating dyslipidemia. The invention relates to the use of compound of formula (I), where the group R has the indicated meanings, and to the physiologically acceptable salts thereof for the production of a pharmaceutical for treating dyslipidemia.

Подробнее
11-11-2005 дата публикации

Substituted 3- (benzoylureido) thiophene derivatives, process for preparation and use thereof

Номер: NO20054168L
Принадлежит: Sanofi Aventis Deutschland

Det beskrives forbindelser med formel I der restene har de angitte betydninger, samt fysiologisk godtagbare salter derav. Forbindelsene kan benyttes for eksempel som medikamenter ved prevensjon og terapi av type 2 diabetes.

Подробнее
14-01-1988 дата публикации

Substituted thienoimidazole derivatives, processes for their preparation, pharmaceutical preparations containing them and their use as gastric acid secretion inhibitors

Номер: DE3623683A1
Принадлежит: Hoechst AG

The invention relates to compounds of the formula <IMAGE> in which A stands for <IMAGE> <IMAGE> or <IMAGE> T denotes -S-, -SO- or -SO2- and R<1> to R<9> have the meanings indicated in the description, processes for their preparation, pharmaceutical preparations containing them and their use as gastric acid secretion inhibitors.

Подробнее
02-11-2004 дата публикации

Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments

Номер: US6812250B2
Принадлежит: Aventis Pharma Deutschland GmbH

The invention relates to carboxamide-substituted phenylurea derivatives and their physiologically tolerated salts and physiologically functional derivatives. Compounds of the formula I in which the radicals have the stated meanings, and the physiologically tolerated salts thereof and process for their preparation are described. The compounds are suitable, for example, for treating type II diabetes.

Подробнее
30-12-2004 дата публикации

Adenosine and adenosine analogues for producing medicines for the treatment of the insulin resistance syndrome and diabetes

Номер: BG108356A
Принадлежит: Aventis Pharma Deutschland GmbH

Изобретението се отнася до приложение на аденозинови съединения с формула и техни производни за получаване на лекарство за лечение на синдрома на инсулиновата резистентност и диабет. Във формулата К е N, N O, или СН; Q е СН2 или О; R6 е водород, алкил, алил, 2-металил, 2-бутенил, или циклоалкил;X е или , Е е О или S; Y е например водород, алкил, аралкил, арил; n и р са независимо 0, 1, 2 или 3, при условие че + р е най-малко 1; Т е например водород, алкил, ацил, тиоацил, хало, карбоксил; R1R2NCO-, R1,R2NCS- или R3OC2H-, като R1, R2 и R3 са независимо Н, алкил, или циклоалкил; А е водород, алкил, хидроксиалкил, алкоксиалкил, или OR'; В е водород, алкил, хидроксиалкил, алкоксиалкил, или OR''; R' и R'' са независимо например водород, алкил, аралкил или карбамоил. а

Подробнее
24-05-2016 дата публикации

spirocyclically substituted 1,3-propane dioxide derivatives, method for their production and use as a medicament

Номер: BR112013000248A2
Принадлежит: SANOFI SA

derivados de dióxido de 1,3-propano espirociclicamente substituído, método para a produção dos mesmos e uso dos mesmos como medicamento. a presente invenção refere-se a derivdos de dióxido de 1,3-propano espiriciclicamente substituídos e seus sais fisiologicamente compatíveis. a invenção refere-se a compostos de fórmula (i) na qual r1,r2,r3,r4,r5,r6,r7,r8, a e x têm os significados fornecidos e seus sais fisiologicamente compatíveis. os compostos são adequados, por exemplo, para o tratamento de diabetes. spirocyclically substituted 1,3-propane dioxide derivatives, method for their production and use as a medicament. The present invention relates to spiricyclically substituted 1,3-propane dioxide derivatives and their physiologically compatible salts. The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, A and X have the meanings provided and their physiologically compatible salts. The compounds are suitable, for example, for the treatment of diabetes.

Подробнее
11-05-2010 дата публикации

4,5-diphenyl-pyrimidinylamino substituted carboxylic acids, method for the production and use thereof as medicaments

Номер: US7713988B2
Принадлежит: Sanofi Aventis France

This invention relates to a compound of formula I, wherein R1, R2, R3, m, n, W, X and Y are as defined herein, or a physiologically tolerated salt thereof, its pharmaceutical composition and use for lowering blood glucose, treating diabetes, or increasing insulin release.

Подробнее
16-10-2003 дата публикации

Acyl-4-carboxyphenylurea derivatives, method for production and use thereof

Номер: CA2481817A1
Принадлежит: Individual

The invention relates to acyl-4-carboxyphenylurea derivatives, the physiologically-acceptable salts, physiologically-functional derivatives thereof and compounds of formula (I), where the groups have the given meanings, the physiologically acceptable salts and method for production thereof. Said compounds are suitable, for example, as anti-diabetics.

Подробнее
31-01-2012 дата публикации

HETEROCYCLICALLY SUBSTITUTED METOXYPHENYL DERIVATIVES WITH AN OXO GROUP, PROCEDURES FOR THE PREPARATION AND USE OF THE SAME AS MEDICATIONS

Номер: UY33458A
Принадлежит: Sanofi Aventis

La invención se refiere a derivados de metoxifenilo heterocíclicamente sustituidos con un grupo oxo, y a sus sales fisiológicamente compatibles. La invención se refiere a compuestos de la fórmula I: en que R1, R2, R3, R4, R10, X, n, B1, B2, B3 y B4 se definen cada uno como se especifica, y a sus sales fisiológicamente compatibles. Los compuestos son adecuados para el tratamiento de la diabetes.

Подробнее
28-04-2004 дата публикации

Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament

Номер: EP1294682B1
Принадлежит: Aventis Pharma Deutschland GmbH

The invention relates to acylphenyl urea derivatives and the physiologically compatible salts and physiologically functional derivatives thereof. Such compounds correspond to the formula (I) wherein the radicals have the cited meanings. The invention also relates to a method for producing said compounds. Said compounds can be used, for example, for treating Type II diabetes.

Подробнее
16-09-2009 дата публикации

Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments

Номер: EP1523471B1
Принадлежит: Sanofi Aventis Deutschland GmbH

The invention relates to urea-substituted and urethane-substituted acylureas, to physiologically compatible salts thereof and to their physiologically functional derivatives. The invention thus relates to compounds of formula (I), wherein the radicals have the cited meanings. The invention also relates to the physiologically compatible salts of these compounds and to methods for the production thereof. The inventive compounds are suited for use, for example, as antidiabetics.

Подробнее
10-02-2005 дата публикации

Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same

Номер: WO2005012244A1
Принадлежит: SANOFI-AVENTIS DEUTSCHLAND GMBH

Die Erfindung betrifft substituierte Benzoylureido-o-benzoylamide sowie deren physiologisch verträgliche Salze und physiologisch funktionelle Derivate. Die Erfindung betrifft Verbindungen der Formel (I), worin die Reste die angegebenen Bedeutungen haben, sowie deren physiologisch verträgliche Salze. Die Verbindungen eignen sich z.B. als Medikamente zur Prävention und Behandlung von Diabetes Typ 2.

Подробнее
02-04-1998 дата публикации

New sulphonamide derivatives of chroman

Номер: DE19639462A1
Принадлежит: Hoechst AG

Chromans of formula (I) and their salts are new: where R(1), R(2) = H, fluoroalkyl, 1-6C alkyl, optionally substituted phenyl; or R(1) and R(2) = 2-10C alkyl chain; R(3) = substituted alkylsulphonamide; R(4) = substituted 1-20C alkyl; R(5), R(6), R(7), R(8) = H, halogen, 1-4C alkyl, 3-8C cycloalkyl, CN, CF3, C2F5, C3F7, N3, NO2, amido, ester, substituted alkyl-sulphone, -ketone, -amine, -ether, or -amide, optionally substituted phenyl; where R(6) <9> OCF3 or OC2F5. Also claimed are compounds of formula (Ia): where R(A) = H, OH, O(CO)-(1-4C alkyl), O(SO2)-(1-4C alkyl); R(B) = H; or R(A) and R(B) = a bond; R(1) -R(4) = as for (I);and R(C) = CN, 1-6C acyl, F, Cl, Br, I, NO2, 1-6C alkyl.

Подробнее
30-09-2013 дата публикации

Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament

Номер: MY149648A
Принадлежит: Sanofi Aventis

THE INVENTION RELATES TO BIS-PHENYL-OXALAMIDES AND THE PHYSIOLOGICALLY COMPATIBLE SALTS THEREOF. THE INVENTION ALSO RELATES TO COMPOUNDS OF FORMULA (I), WHEREIN R1, R2, R3, R4, R5, R6, R7, R8, M AND X HAVE THE CITED DESIGNATIONS, AND TO THE PHYSIOLOGICALLY COMPATIBLE SALTS THEREOF. THE COMPOUNDS ARE SUITABLE, FOR EXAMPLE, FOR THE TREATMENT OF DIABETES.

Подробнее
05-08-2004 дата публикации

Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof

Номер: CA2513286A1

The invention relates to compounds of formula (I) wherein the radicals have the cited meaning, in addition to the physiologically compatible salts thereof. The compounds, for example, can be used as medicaments for preventing and treating type 2 diabetes.

Подробнее
29-12-2000 дата публикации

Cyclohexane derivatives, method of obtaining them and their application in treating diseases

Номер: PL180074B1
Принадлежит: Hoechst AG

Cyclohexane derivs. of formula (I), and their salts, are new. R<2> = O-(3-5C)alkyl-R<11>, in which the alkyl component is straight, branched or cyclic; R<11> = phenyl (opt. 4-substd. by F, Cl or Me); and R<4>, R<5> = H or OH.

Подробнее
16-10-2003 дата публикации

Acyl-3-carboxyphenylurea derivatives, method for production and use thereof

Номер: WO2003084923A1
Принадлежит: Aventis Pharma Deutschland GmbH

Die Erfindung betrifft Acyl-3-carboxyphenyl-Harnstoffderivate sowie deren physiologisch verträgliche Salze und physiologisch funktionelle Derivate. Die Erfindung betrifft Verbindungen der Formel (I), worin die Reste die angegebenen Bedeutungen haben, sowie deren physiologisch verträglichen Salze und Verfahren zu deren Herstellung. Die Verbindungen eignen sich z.B. als Antidiabetika.

Подробнее
01-09-2010 дата публикации

(Carboxylalkylphenyl) Phenloxamide, its production processes and its use as a drug

Номер: MA31710B1
Принадлежит: Sanofi Aventis

La présente invention concerne des bis-phényl-oxalamides ainsi que leurs sels physiologiquement acceptables. La présente invention concerne des composés de la formule (i), dans laquelle rl, r2, r3, r4, r5, r6, r7, r8, m et x ont les significations indiquées, ainsi que les sels physiologiquement acceptables des composés de formule (i). Les composés sont par exemple appropriés pour le traitement du diabète. The present invention relates to bis-phenyl-oxalamides and their physiologically acceptable salts. The present invention relates to compounds of formula (i), wherein r1, r2, r3, r4, r5, r6, r7, r8, m and x have the indicated meanings, as well as the physiologically acceptable salts of compounds of formula ( i). The compounds are, for example, suitable for the treatment of diabetes.

Подробнее
22-01-2004 дата публикации

Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments

Номер: WO2004007437A1
Принадлежит: Aventis Pharma Deutschland GmbH

The invention relates to urea-substituted and urethane-substituted acylureas, to physiologically compatible salts thereof and to their physiologically functional derivatives. The invention thus relates to compounds of formula (I), wherein the radicals have the cited meanings. The invention also relates to the physiologically compatible salts of these compounds and to methods for the production thereof. The inventive compounds are suited for use, for example, as antidiabetics.

Подробнее
06-11-2003 дата публикации

Acyl-4-carboxyphenyl-urea derivatives, processes for their preparation and their use

Номер: DE10215907A1
Принадлежит: Aventis Pharma Deutschland GmbH

Die Erfindung betrifft Acyl-4-carboxyphenyl-harnstoffderivate sowie deren physiologisch verträgliche Salze und physiologisch funktionelle Derivate. DOLLAR A Die Erfindung betrifft Verbindungen der Formel I, DOLLAR F1 worin die Reste die angegebenen Bedeutungen haben, sowie deren physiologisch verträgliche Salze und Verfahren zu deren Herstellung. Die Verbindungen eignen sich z. B. als Antidiabetika. The invention relates to acyl-4-carboxyphenyl-urea derivatives and their physiologically acceptable salts and physiologically functional derivatives. DOLLAR A The invention relates to compounds of the formula I, DOLLAR F1 wherein the radicals have the meanings indicated, and their physiologically acceptable salts and processes for their preparation. The compounds are suitable for. B. as antidiabetics.

Подробнее
22-01-2004 дата публикации

Heterocyclically substituted benzoylureas, method for their production and their use as medicaments

Номер: WO2004007455A1
Принадлежит: Aventis Pharma Deutschland GmbH

The invention relates to heterocyclically substituted benzoylureas, in addition to their physiologically compatible salts and physiologically functional derivatives. The invention relates in particular to compounds of formula (I), in which the groups are defined as cited in the description, in addition to their physiologically compatible salts and to a method for producing said compounds. The compounds are suitable e.g. for treating type 2 diabetes.

Подробнее
22-04-2004 дата публикации

Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine

Номер: CA2500763A1
Принадлежит: Individual

The invention concerns carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives of formula (I) wherein the groups are such as defined in the description and their physiologically acceptable salts and their physiologically functional derivatives. The invention also concerns a method for producing said compounds which can be used for example for treating type II diabetes.

Подробнее